Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
16 Dec 2016 ESMO Asia 2016 Press Release: Asian Head and Neck Cancer Patients Live Longer with Immunotherapy than Mixed Race Group Head and neck cancers
15 Dec 2016 EMA Hosts Workshop on Adaptive Pathways Bioethics, legal and economic issues
14 Dec 2016 ESMO Thanks Oncology Nurses for Their Outstanding Contribution in the Review of the Patient Guides
14 Dec 2016 ESMO Asia 2016 Press Release: Almost 20% of Breast Cancer Patients Fail to Complete Prescribed Endocrine Therapy Breast cancer
13 Dec 2016 Clinical Responses and Mutation Clearance After Decitabine in Patients with AML and MDS Translational research - Haematologic malignancies - Anticancer agents & Biologic therapy
12 Dec 2016 PI3K Inhibitor Buparlisib in Combination with Fulvestrant Prolongs PFS Compared to Placebo Plus Fulvestrant Translational research - Anticancer agents & Biologic therapy
09 Dec 2016 CAR T-Cell Immunotherapy Induces Complete Remissions in Patients with Refractory DLBCL Haematologic malignancies - Cancer Immunology and Immunotherapy
07 Dec 2016 Durvalumab in Heavily Pretreated EGFR/ALK Wildtype Advanced NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
07 Dec 2016 ESMO Asia 2016 Press Release: Supportive Care for Cancer Patients Remains Inadequate Palliative and supportive care
07 Dec 2016 ESMO Asia 2016 Press Release: Patients Wait Four Months Before Seeking Cancer Diagnosis
06 Dec 2016 PFS Significantly Longer With Osimertinib Than With Platinum-Pemetrexed in EGFR T790M-Positive Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
05 Dec 2016 Suicide in Survivors of Cancer in Childhood, Adolescence and Young Adulthood Cancer in Special Situations
25 Nov 2016 ESC Position Paper on Anticancer Treatments and Cardiovascular Toxicity Palliative and supportive care
24 Nov 2016 NICE Issues Evidence Based Recommendations on Nivolumab for Previously Treated Advanced RCC Genitourinary cancers - Cancer Immunology and Immunotherapy
23 Nov 2016 FDA Approves Daratumumab in Combination with Lenalidomide and Dexamethasone or Bortezomib and Dexamethasone for Multiple Myeloma Treatment Haematologic malignancies - Anticancer agents & Biologic therapy